Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9697138 | 0.81 | KMT2A (0.34) | KMT2AKDM4EKCNK3ALDH1A1TDP1 | |
| SCHEMBL9696229 | 0.77 | KMT2A (0.43) | KMT2AKDM4EKCNK3ALDH1A1LMNA | |
| SCHEMBL9697147 | 0.76 | KMT2A (0.67) | KMT2AKDM4EKCNK3ALDH1A1LMNA | |
| SCHEMBL9696399 | 0.75 | KMT2A (0.45) | KMT2AKDM4EKCNK3ALDH1A1LMNA | |
| SCHEMBL9697128 | 0.70 | KMT2A (0.39) | KMT2A | |
| SCHEMBL9696274 | 0.66 | KMT2A (0.39) | KMT2A | |
| SCHEMBL9696283 | 0.66 | KMT2A (0.39) | KMT2A | |
| SCHEMBL9697349 | 0.66 | KMT2A (0.39) | KMT2A | |
| SCHEMBL9780839 | 0.63 | ALDH1A1 (0.34) | KMT2AKCNK3ALDH1A1 | |
| SCHEMBL9696155 | 0.63 | KMT2A (0.35) | KMT2AKDM4EKCNK3ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5124453-A | Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide | E. R. SQUIBB & SONS, INC. (US) | 1992-06-23 | — | — | US | disclosed |
| EP-0444532-A1 | Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method | E.R. SQUIBB & SONS, INC. (US) | 1991-09-04 | — | — | EP | disclosed |
| US-5025000-A | Anticholesterol, antilipemic agents | E. R. SQUIBB & SONS, INC. (US) | 1991-06-18 | — | — | US | disclosed |